Literature DB >> 2113565

Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts.

D B Kaufman1, J L Platt, F L Rabe, D L Dunn, F H Bach, D E Sutherland.   

Abstract

The high rate of persistent hyperglycemia, termed primary nonfunction, after islet allotransplantation in C57BL/6 mice recipients of B10.BR strain islets, as compared with B10.BR recipients of C57BL/6 islets, led to a series of experiments to determine whether islet allograft primary nonfunction was attributable to technical aspects of the transplant procedure or whether it was a consequence of alloimmunity. Primary nonfunction was prevented by systemic pharmacologic immunosuppression of the host with cyclosporine. Selective immunodepletion of host CD4+ and CD8+ T lymphocytes significantly extended the time of classic rejection but did not significantly affect the rate of primary nonfunction. However, modulation of macrophages by administration to the host of silica completely abolished primary nonfunction. These observations, in conjunction with the immunohistological findings of intense macrophage infiltration in islet allografts from recipients exhibiting persistent post-transplant hyperglycemia, support the hypothesis that primary nonfunction results from a cell-mediated host-immune response of rapid onset that is dependent on macrophages or macrophage byproducts as the main effectors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113565      PMCID: PMC2188153          DOI: 10.1084/jem.172.1.291

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Effects of silica on macrophages and lymphocytes.

Authors:  H Van Loveren; M Snoek; W Den Otter
Journal:  J Reticuloendothel Soc       Date:  1977-12

2.  On the variability of outcome after islet allotransplantation.

Authors:  D B Kaufman; F Rabe; J L Platt; P G Stock; D E Sutherland
Journal:  Transplantation       Date:  1988-06       Impact factor: 4.939

Review 3.  Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis.

Authors:  M Sarmiento; D P Dialynas; D W Lancki; K A Wall; M I Lorber; M R Loken; F W Fitch
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  H-2 antigen class: effect on mouse islet allograft rejection.

Authors:  C E Morrow; D E Sutherland; M W Steffes; J S Najarian; F H Bach
Journal:  Science       Date:  1983-03-18       Impact factor: 47.728

5.  Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine.

Authors:  J L Platt; A F Michael
Journal:  J Histochem Cytochem       Date:  1983-06       Impact factor: 2.479

Review 6.  Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.

Authors:  D P Dialynas; D B Wilde; P Marrack; A Pierres; K A Wall; W Havran; G Otten; M R Loken; M Pierres; J Kappler
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

7.  Dynamic time course studies of the spontaneously diabetic BB Wistar rat. III. Light-microscopic and ultrastructural observations of pancreatic islets of Langerhans.

Authors:  T A Seemayer; G S Tannenbaum; H Goldman; E Colle
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

8.  Differences in susceptibility to rejection of mouse pancreatic islet allografts disparate for class I or class II major histocompatibility antigens.

Authors:  C E Morrow; D E Sutherland; M W Steffes; D Kaufman; J S Najarian; F H Bach
Journal:  J Surg Res       Date:  1983-04       Impact factor: 2.192

9.  Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis.

Authors:  J S Najarian; D E Sutherland; D Baumgartner; B Burke; J J Rynasiewicz; A J Matas; F C Goetz
Journal:  Ann Surg       Date:  1980       Impact factor: 12.969

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  28 in total

1.  Saving islets from allograft rejection.

Authors:  Terry B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

Review 2.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

3.  CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants.

Authors:  Andrew E Gelman; Mikio Okazaki; Jiaming Lai; Christopher G Kornfeld; Friederike H Kreisel; Steven B Richardson; Seiichiro Sugimoto; Jeremy R Tietjens; G Alexander Patterson; Alexander S Krupnick; Daniel Kreisel
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 4.  Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.

Authors:  David L Morris
Journal:  Mol Endocrinol       Date:  2015-05-22

Review 5.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 6.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

7.  Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant.

Authors:  Jonathan S Rink; Xiaojuan Chen; Xiaomin Zhang; Dixon B Kaufman
Journal:  Surgery       Date:  2011-10-06       Impact factor: 3.982

8.  Co-incubation of pig islet cells with spleen cells from non-obese diabetic mice causes decreased insulin release by non-T-cell- and T-cell-mediated mechanisms.

Authors:  S You; A S Rivereau; E Gouin; P Saï
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

9.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09

Review 10.  Current advances and travails in islet transplantation.

Authors:  David M Harlan; Norma Sue Kenyon; Olle Korsgren; Bart O Roep
Journal:  Diabetes       Date:  2009-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.